Featured insights

The latest at the Foundation

Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation.

News

Foundation's new report reveals what pharma companies can do to ensure their products reach underserved populations

10 September 2024

Media

Pharma is still struggling to widen access to medicines - and reach patients - in low- and middle-income countries

10 September 2024

News

New 2024 Index Methodology places greater focus on measuring patient reach

10 October 2023

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

23 May 2024

Resource Center

Explore our research reports and publications

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023

Event

Joint event with World Economic Forum on the evolving role of generics – Meeting Report

21 June 2023

News

Foundation names Expert Review Committee for next AMR Benchmark

03 September 2024

News

Latest Amsterdam Session identifies strategies to accelerate expansion of diabetes care in LMICs

07 May 2024

2022 Ranking

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

Featured Media

Combating superbugs: How Indian drugmakers can address the global shortfall in antibiotic development

06 June 2024

Media

Pharma must ramp up access, stewardship efforts in AMR research, new report finds

23 May 2024

Media

Op-ed: There are far too many avoidable deaths in childbirth

18 January 2024

Achievements so far

Closing the gaps in access to diabetes care in low- and middle-income countries

07 July 2022

News

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries

16 June 2021